These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7587092)

  • 1. Role of a cell cycle regulator in hereditary and sporadic cancer.
    Kamb A
    Cold Spring Harb Symp Quant Biol; 1994; 59():39-47. PubMed ID: 7587092
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-cycle regulators and cancer.
    Kamb A
    Trends Genet; 1995 Apr; 11(4):136-40. PubMed ID: 7732591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppression. Lessons in p16 from phylum Falconium.
    Sheaff RJ; Roberts JM
    Curr Biol; 1995 Jan; 5(1):28-31. PubMed ID: 7697342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cell cycle regulator potentially involved in genesis of many tumor types.
    Kamb A; Gruis NA; Weaver-Feldhaus J; Liu Q; Harshman K; Tavtigian SV; Stockert E; Day RS; Johnson BE; Skolnick MH
    Science; 1994 Apr; 264(5157):436-40. PubMed ID: 8153634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tumor suppressor may rival p53.
    Marx J
    Science; 1994 Apr; 264(5157):344-5. PubMed ID: 8153613
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system.
    Wang Y; Becker D
    Oncogene; 1996 Mar; 12(5):1069-75. PubMed ID: 8649798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Link to hereditary melanoma brightens mood for p16 gene.
    Marx J
    Science; 1994 Sep; 265(5177):1364-5. PubMed ID: 8073268
    [No Abstract]   [Full Text] [Related]  

  • 8. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.
    Reed JA; Loganzo F; Shea CR; Walker GJ; Flores JF; Glendening JM; Bogdany JK; Shiel MJ; Haluska FG; Fountain JW
    Cancer Res; 1995 Jul; 55(13):2713-8. PubMed ID: 7796391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression.
    Piccinin S; Doglioni C; Maestro R; Vukosavljevic T; Gasparotto D; D'Orazi C; Boiocchi M
    Int J Cancer; 1997 Feb; 74(1):26-30. PubMed ID: 9036865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
    Flores JF; Walker GJ; Glendening JM; Haluska FG; Castresana JS; Rubio MP; Pastorfide GC; Boyer LA; Kao WH; Bulyk ML; Barnhill RL; Hayward NK; Housman DE; Fountain JW
    Cancer Res; 1996 Nov; 56(21):5023-32. PubMed ID: 8895759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A challenge to p16 gene as a major tumor suppressor.
    Marx J
    Science; 1994 Jun; 264(5167):1846. PubMed ID: 8009205
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation and function of the cyclin-dependent kinase inhibitor p16CDKN2.
    Peters G; Parry D; Hara E; Hall M; Bates S; Palmero I
    Leukemia; 1997 Apr; 11 Suppl 3():352-5. PubMed ID: 9209387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient.
    Glendening JM; Flores JF; Walker GJ; Stone S; Albino AP; Fountain JW
    Cancer Res; 1995 Dec; 55(23):5531-5. PubMed ID: 7585628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CDKN2A (p16) gene and human cancer.
    Foulkes WD; Flanders TY; Pollock PM; Hayward NK
    Mol Med; 1997 Jan; 3(1):5-20. PubMed ID: 9132280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of p16 (MTS1) mutations in primary tumors with 9p loss.
    Cairns P; Mao L; Merlo A; Lee DJ; Schwab D; Eby Y; Tokino K; van der Riet P; Blaugrund JE; Sidransky D
    Science; 1994 Jul; 265(5170):415-7. PubMed ID: 8023167
    [No Abstract]   [Full Text] [Related]  

  • 16. p16INK4A as a human tumor suppressor.
    Shapiro GI; Rollins BJ
    Biochim Biophys Acta; 1996 Mar; 1242(3):165-9. PubMed ID: 8603068
    [No Abstract]   [Full Text] [Related]  

  • 17. Sunlight and melanoma: an answer from MTS1 (p16).
    Maestro R; Boiocchi M
    Science; 1995 Jan; 267(5194):15-6. PubMed ID: 7809600
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage.
    Talve L; Sauroja I; Collan Y; Punnonen K; Ekfors T
    Int J Cancer; 1997 Jun; 74(3):255-9. PubMed ID: 9221801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressor genes. Open questions on p16.
    Bonetta L
    Nature; 1994 Jul; 370(6486):180. PubMed ID: 8028659
    [No Abstract]   [Full Text] [Related]  

  • 20. CDKN2 mutations in melanoma.
    Dracopoli NC; Fountain JW
    Cancer Surv; 1996; 26():115-32. PubMed ID: 8783570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.